Latest Asx Company Filings News

AUB Group has approved EQT's partnership with CVC Asia Pacific to jointly pursue a $45 per share acquisition, extending exclusivity to December 4 as due diligence continues.

Marmota Limited is advancing its Greenewood gold project with a substantial Stage 2 drilling campaign following exceptional bonanza-grade results from its maiden program. The upcoming program aims to build on promising early assays that highlight Greenewood’s potential as a key asset in the Gawler Craton.

The a2 Milk Company is expanding its strategic partnership with China State Farm to include English label infant milk formula products, starting with a2 Genesis™ in early 2026. This move aims to strengthen distribution control and capitalize on China’s booming infant formula market.

GoviEx Uranium has received the Supreme Court of British Columbia's final approval for its reverse takeover of Tombador Iron, setting the stage for completion by mid-November 2025.

Epsilon Healthcare reports a strong rebound with a 73% revenue increase in the June quarter, driven by contract manufacturing and new pharmacy operations. The company is emerging from restructuring with renewed financial strength and growth prospects.

Wisr Limited has announced an $11.4 million equity raise alongside an upgraded FY26 outlook and a non-binding term sheet to refinance its debt at lower interest rates, positioning the fintech lender for profitability in the second half of FY26.

Solvar Limited has secured a new $487 million warehouse facility and resized an existing $270 million facility, boosting its total funding capacity to around $900 million and reducing its cost of funds.

Savannah Goldfields has resumed gold production at its Georgetown plant, pouring its first doré since early 2024, while preparing to commence mining at Big Reef and expand operations at Agate Creek.

Kuniko Limited has completed a key airborne geophysical survey and begun field sampling at its Commonwealth Gold-Silver Project in NSW, setting the stage for maiden drilling in early 2026. These steps fulfill joint venture commitments and maintain licence status in a prolific mineral region.

Mayne Pharma’s acquisition by Cosette Pharmaceuticals faces a regulatory delay as the Foreign Investment Review Board extends its approval deadline, pushing the court hearing to mid-November.

Argent Minerals is set to commence a significant drilling program targeting silver and gold mineralisation at its flagship Kempfield and Trunkey Creek projects in New South Wales. The campaign aims to expand known resources and explore new zones across multiple high-priority targets.

EQT has reaffirmed its intention to acquire AUB Group at $45 per share, extending its exclusivity period for due diligence by two weeks. While the proposal remains non-binding, this development keeps acquisition talks firmly on the table.